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Effects of Ik,Ach Channel Inhibitor Tertiapin-Q on Right Atrial Prepara-
tions from Patients in Sinus Rhythm and Atrial Fibrillation
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1Pharmacology and Toxicology, Technical University of Dresden, Dresden,
Germany, 2Biology, Gilead Sciences, Fremont, CA, USA, 3Cardiovascular
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Background: The acetylcholine-activated inward rectifying current, IK,Ach, has
been suggested as a novel atrial-selective putative drug target for the treat-
ment of atrial fibrillation (AF). Here we have studied the effects of a selective
IK,ACh channel inhibitor tertiapin-Q in human right atrial preparations from
patients in sinus rhythm (SR) and permanent chronic atrial fibrillation
(AF, >6 months).
Methods: Action potentials (APs) were measured using sharp electrodes in
right atrial trabeculae or patch electrodes in cardiomyocytes from patients un-
dergoing open heart surgery (48 in SR and 34 in AF).
Results and Conclusion: Tertiapin-Q (300nM) did not affect APs recorded in
AF trabeculae (APD90 at 1Hz: control 205.859.0ms vs. drug 209.059.0ms,
n.s.). Consistent with electrical remodelling of IK,ACh channels in AF,
1mM carbachol caused minimal effect on APD in AF trabeculae and no
further effect was detected following combined exposure to carbachol and
tertiapin-Q (APD90 242.0516.9ms, 233.0520.5ms, 234.0519.1ms, respec-
tively). In SR trabeculae, tertiapin-Q modestly, though not significantly, atten-
uated the shortening effect of carbachol on APD90: 310.057.7ms,
215.0516.4ms, and 254.0517.8ms, respectively). In the continuous presence
of carbachol and tetrodotoxin (1mM), tertiapin-Q prolonged effective refrac-
tory period and APD90. In atrial cardiomyocytes from SR patients,
tertiapin-Q fully reversed the carbachol-induced shortening of APD90. At a
holding potential of 80mV, tertiapin-Q had no effect on the basal inward
current in SR cardiomyocytes (2.050.5pA/pF vs. 2.550.7pA/pF, n¼7), but
significantly reduced in AF cardiomyocytes (6.851.1pA/pF vs. 5.950.8pA/
pF, P<0.05, n¼12), providing evidence for constitutive activity of IK,ACh in
AF cardiomyocytes. From the modest effects of tertiapin-Q in multicellular
preparations in comparison to cardiomyocytes, we conclude that access of
the IK,ACh channel inhibitor to its target may be limited in intact superfused
tissues.
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Voltage-gated potassium channels (Kv) regulate pancreatic b-cell excitability,
and thereby insulin secretion. Kv channels are modulated by ancillary cyto-
plasmic subunits, such as the Kvb proteins. In this study, we investigated the
electrophysiology of pancreatic b-cells and isolated islet function in mice lack-
ing the Kvb2 gene.
Methods: Islets from Kvb2-/- (KO) and wild-type (WT) mice were enzy-
matically isolated and disrupted into single cells. Whole-cell voltage
clamp was used to measure Kv kinetics. Action potentials were recorded
using the perforated-patch technique. Glucose stimulated insulin secretion
was measured in isolated WT and KO islets. Mice underwent metabolic
characterization.
Results: Kvb2 expression in WT islets was demonstrated by qRT-PCR and
Western. Compared with cells from WT mice, KO b-cells had a depolarized
half-activation voltage (V1/2-act), p<0.01. The Kv-blocker 4-aminopyridine
(4AP) was used to characterize the Kv current. The IC50 of the 4AP-sensitive
current was 190mM. Total b-cell Kv amplitude blocked by 4AP was
34.152.6% at 500mM. Together, this suggests Kv1-family proteins may
contribute significantly to b-cell repolarization. Kvb2 is known to modulate
Kv1-family currents by increasing surface expression, shifting V1/2-act, and
altering channel inactivation. Insulin release from KO islets at 2.5mM glucose,
3.2650.25 ng/mL/hr/5 islets, was greater than inWT islets, 0.6450.23 ng/mL/
hr, p¼0.002. Fasting plasma insulin was higher in KO than in WT, p<0.025,
and KO had lower fasting blood glucose, p<0.0001. An intraperitoneal injec-
tion of glucose showed KO to have enhanced glucose tolerance as compared to
WT. When housed in metabolic cages, KO mice had higher metabolic rates
than age-matched WT.
Conclusion: Deletion of Kvb2 alters the metabolic phenotype and may be
related to increased release of insulin by the murine pancreas due to altered
b-cell repolarization. These findings reveal a critical role of Kvb2 in regulating
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Pharmacological Consequences of PKC Inhibition on Kv1.5DKvbeta1.3
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The Kvb1.3 subunit modifies the gating and pharmacology of Kv1.5 channels
in a PKC-dependent manner, decreasing channel sensitivity to bupivacaine-
and quinidine-mediated blockade. Cardiac Kv1.5 channels associate with re-
ceptor for activated C kinase 1 (RACK1), the Kvb1.3 subunit and different
PKC isoforms, resulting in the formation of a functional channelosome. The
aim of the present study was to investigate the effects of PKC inhibition on
bupivacaine and quinidine block of Kv1.5 þ Kvb1.3 channels. HEK293 cells
were transfected with Kv1.5 þ Kvb1.3 channels, and currents were recorded
using the whole-cell configuration of the patch-clamp technique. PKC inhibi-
tion was achieved by incubating the cells with either calphostin C or bisindo-
lylmaleimide II and the effects of bupivacaine and quinidine were analysed.
The voltage-dependent inactivation of Kv1.5 þ Kvb1.3 channels and their
pharmacological behavior after PKC inhibition with calphostin C were similar
to those displayed by Kv1.5 channels alone. Indeed, the IC50 values for
bupivacaine were similar in cells whose PKC was inhibited with calphostin
C or bisindolylmaleimide II. Similar results were also observed in the pres-
ence of quinidine. The finding that the voltage-dependence of inactivation
and the pharmacology of Kv1.5 þ Kvb1.3 channels after PKC inhibition
resembled that observed in Kv1.5 channels suggests that both processes are
dependent on PKC-mediated phosphorylation. These results may have clinical
relevance in diseases that are characterized by alterations in kinase activity.
Supported by SAF2010-14916, SAF2013-45800-R and FIS-RIC RD12/
0042/0019 Grants.
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Inward rectifier potassium (Kir) channels are expressed in numerous mamma-
lian tissues including the pancreas, brain, heart, and skeletal muscle and play
a critical role in controlling cellular excitability. Pancreatic ATP-sensitive
Kir (KATP) channels are key regulators of insulin secretion as they link
cellular metabolism with membrane excitability. Loss-of-function (LOF)
mutations in KATP can cause human hyperinsulinism as a result of dimin-
ished activity. Several of these LOF mutations disrupt salt-bridge interactions
that are located within the intracellular subunit-subunit interfaces, and
result in channel activity showing a fast inactivation following ATP
removal as measured with the inside-out patch clamp technique. Inactivation
can be subsequently abolished by application of PIP2 to the cytoplasmic face
of the membrane, an action that can be explained by a simple model in
which PIP2 competes with the closed inactivated state. We find that homolo-
gous mutations in the strong inward rectifying Kir2.1 channel cause lower
basal activity as a result of reduced apparent PIP2 sensitivity, indicating
increased inactivation. Kir2.1 channels contain additional intersubunit salt-
bridge interactions that are not present in KATP channels. Introduction of
these salt-bridges into the inactivating KATP channel mutants partially res-
cues the channel from this inactivating phenotype. These results lead us to
propose that the stability of the intersubunit interface regulates channel inac-
tivation, sensitivity to PIP2, and is conserved across the Kir channel family
and stabilizing the intersubunit interface provides a potential strategy to
exploit in development of activating modulators of KATP and other Kir
channels
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We have previously shown that KChIP4s reduces surface expression of
Kv4 through its N-terminal KID (Kv4 inhibitory domain) that causes
endoplasmic reticulum retention of the channel complex. In this study
we found that treatment of HEK 293 cells expressing KChIP4a with cyclo-
heximide that inhibits protein synthesis causes a significant degradation of
